Pathstone Family Office’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,354
| Closed | -$207K | – | 1385 |
|
|
2022
Q4 | $207K | Buy |
+5,354
| New | +$207K | ﹤0.01% | 1373 |
|
|
2021
Q1 | – | Sell |
-15
| Closed | – | – | 1076 |
|
|
2020
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 1257 |
|
|
2020
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 936 |
|
|
2020
Q2 | $0 | Sell |
15
-72
| -83% | – | ﹤0.01% | 888 |
|
|
2020
Q1 | $1K | Buy |
+87
| New | +$1K | ﹤0.01% | 723 |
|
|
2019
Q2 | – | Sell |
-89
| Closed | -$3K | – | 806 |
|
|
2019
Q1 | $3K | Hold |
89
| – | – | ﹤0.01% | 699 |
|
|
2018
Q4 | $3K | Buy |
+89
| New | +$3K | ﹤0.01% | 419 |
|